Bayer

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

News

Bayer taps Samsung wearables for menopause sleep study

Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineff

News

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

Bayer’s first-quarter results update shows that its workforce has declined by more than 1,500 full-time equivalent (FTE) employees since the end of last year, suggesting r

News

FDA fast-tracks AskBio’s heart failure gene therapy

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficac

News

Bayer, Google partner on AI for time-pressed radiologists

Bayer has joined forces with Google Cloud to continue development of an artificial intelligence-powered platform to help radiologists diagnose patients quicker and more ef

News

Sebastian Guth is promoted to chief operating officer, while Christine Roth will head new global commmercialisation unit

Guth named COO as Bayer revamps top pharma team

Bayer chief executive Bill Anderson has followed through on a pledge to streamline the group’s management, starting at the very top with a big reduction in the pharma unit

FDA widens label for BMS’ cancer drug Augtyro

Bayer taps Samsung wearables for menopause sleep study

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

FDA fast-tracks AskBio’s heart failure gene therapy

Bayer, Google partner on AI for time-pressed radiologists

Guth named COO as Bayer revamps top pharma team

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Bayer

Editor's Picks